AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 221 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 12.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,767 | -20.0% | 212,368 | 0.0% | 0.02% | -14.8% |
| Q2 2023 | $12,205 | +880.3% | 212,368 | +539.7% | 0.03% | +800.0% |
| Q1 2023 | $1,245 | +315.0% | 33,200 | +210.3% | 0.00% | +200.0% |
| Q4 2022 | $300 | -99.9% | 10,700 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $301,000 | -93.2% | 10,700 | -91.6% | 0.00% | -90.0% |
| Q2 2022 | $4,420,000 | -11.9% | 127,053 | -9.1% | 0.01% | +11.1% |
| Q1 2022 | $5,017,000 | +153.9% | 139,753 | +64.7% | 0.01% | +200.0% |
| Q4 2021 | $1,976,000 | +110.9% | 84,846 | +72.1% | 0.00% | +50.0% |
| Q3 2021 | $937,000 | +53.1% | 49,300 | +62.2% | 0.00% | +100.0% |
| Q2 2021 | $612,000 | – | 30,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LAM GROUP, INC. | 128,000 | $5,886,720 | 5.78% |
| Beacon Harbor Wealth Advisors, Inc. | 103,095 | $4,741 | 1.58% |
| Capital Impact Advisors, LLC | 15,304 | $703,831 | 1.18% |
| Quantedge Capital Pte Ltd | 36,389 | $1,673,530 | 0.91% |
| Mesirow Institutional Investment Management, Inc. | 183,805 | $8,453,192 | 0.86% |
| Monashee Investment Management LLC | 39,461 | $1,814,811 | 0.76% |
| OBERWEIS ASSET MANAGEMENT INC/ | 152,500 | $7,013,475 | 0.74% |
| Granite Investment Partners, LLC | 330,911 | $15,218,597 | 0.64% |
| Portolan Capital Management | 132,850 | $6,109,772 | 0.57% |
| SHAKER INVESTMENTS LLC/OH | 20,795 | $956,362 | 0.53% |